204 related articles for article (PubMed ID: 23622661)
1. Case report: binding of a clinically relevant human leukocyte antigen-DQα-specific antibody in a kidney graft recipient is inhibited by donor-type human leukocyte antigen-DQβ chain.
Mikkelsen S; Korsholm T; Iburg A; Petersen MS; Møller BK
Transplant Proc; 2013 Apr; 45(3):1209-12. PubMed ID: 23622661
[TBL] [Abstract][Full Text] [Related]
2. The DQ barrier: improving organ allocation equity using HLA-DQ information.
Tambur AR; Leventhal JR; Zitzner JR; Walsh RC; Friedewald JJ
Transplantation; 2013 Feb; 95(4):635-40. PubMed ID: 23288109
[TBL] [Abstract][Full Text] [Related]
3. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
[TBL] [Abstract][Full Text] [Related]
4. Epitope analysis of HLA-DQ antigens: what does the antibody see?
Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.
Liu W; Kang ZY; Wang ZL; Li DH
Transpl Immunol; 2022 Aug; 73():101607. PubMed ID: 35477043
[TBL] [Abstract][Full Text] [Related]
6. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines.
El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI
Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161
[TBL] [Abstract][Full Text] [Related]
7. The dilemma of DQ HLA-antibodies.
Al Attas R; Al Abduladheem D; Shawhatti AA; Lopez R; Liacini A; AlZahrani S; Akkari K; Hasan N; Alabadi A
Hum Immunol; 2015 May; 76(5):324-8. PubMed ID: 25814447
[TBL] [Abstract][Full Text] [Related]
8. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
9. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
10. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
11. The combination of several polymorphic amino acid residues in the DQalpha and DQbeta chains forms a domain structure pattern and is associated with insulin-dependent diabetes mellitus.
Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A
Ann N Y Acad Sci; 2002 Apr; 958():362-75. PubMed ID: 12021143
[TBL] [Abstract][Full Text] [Related]
12. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
[TBL] [Abstract][Full Text] [Related]
13. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
[TBL] [Abstract][Full Text] [Related]
14. Separating the Wheat from the Chaff among HLA-DQ Eplets.
Devriese M; Lemonnier FA; Lion J; Sayegh C; Fleury E; Shofstall C; Giraldo L; Fiachetti Q; Usureau C; Miyadera H; Toutirais O; Mooney N; Lowe D; Taupin JL
J Immunol; 2024 Jun; 212(12):1981-1991. PubMed ID: 38647382
[TBL] [Abstract][Full Text] [Related]
15. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
16. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
[TBL] [Abstract][Full Text] [Related]
17. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
18. Highly Immunogenic DQB1 Mismatch Eplets Are Associated With Development of Chronic Active Antibody-Mediated Rejection: A First Report From Japan.
Iwami D; Hotta K; Sasaki H; Hirose T; Higuchi H; Takada Y; Shinohara N
Transplant Proc; 2017; 49(1):84-87. PubMed ID: 28104165
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
20. New DQA1 allele specific antibody against epitope 2D (an exon 1 encoded amino acid). Considerations for alleles under the same P-group designation.
Youngs D; Warner P; Gallagher M; Gimferrer I
Transpl Immunol; 2018 Dec; 51():32-39. PubMed ID: 30153474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
